Biography

Nathan A. Brown is a partner in the health care and life sciences practice who focuses on food and drug law, particularly as it relates to medical devices, software, and diagnostics, as well as drugs and biologics. His practice covers regulatory, compliance and policy advice, ranging from early stage product development through postmarket enforcement. He has also played a leading role in developing and advising on many FDA-related legislative reforms in recent years, particularly relating to the device and diagnostics industries.

Prior to joining the firm, Mr. Brown served in several prominent roles with the FDA. He served on detail as health policy advisor to the Senate Health, Education, Labor and Pensions (HELP) Committee to cover FDA issues. He also served as special assistant to the chief counsel, counseling FDA leadership on high priority and cross-cutting matters, including emerging public health issues, high-profile enforcement cases and congressional investigations. During his time in the Office of the Chief Counsel (OCC), he advised FDA’s Center for Devices and Radiological Health on a wide range of matters, including device review program reform, guidance development, software and health IT regulation, third-party review, advanced diagnostics and laboratory developed tests, administrative appeals, and user fee negotiations. Mr. Brown also served as senior counselor to the associate commissioner for regulatory affairs (ACRA) in the Office of Regulatory Affairs (ORA), where he advised the ACRA on compliance, enforcement and policy matters. He represented the ACRA in meetings with industry and in discussions with foreign governments regarding comparability and trade agreements. 

Prior to his tenure at FDA, Mr. Brown was a lawyer in private practice, providing regulatory, legislative and litigation counsel to national associations, public and non-profit hospitals and other health care providers in a wide range of issues relating to Medicaid, Medicare and other health programs. He represented clients before the Centers for Medicare & Medicaid Services, the Department of Health and Human Services Departmental Appeals Board, various state agencies and in litigation in federal and state courts. He also advised clients on election law and lobbying law requirements. 

He is a graduate of Harvard Law School and the University of Maryland.